Annual Drug Patent Expirations for ORGOVYX
Orgovyx is a drug marketed by Myovant Sciences and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has ninety-four patent family members in thirty-three countries.
The generic ingredient in ORGOVYX is relugolix. One supplier is listed for this compound. Additional details are available on the relugolix profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Myovant Sciences drug ORGOVYX
You must log in to post a comment.